Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Mulet

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Blood|March 29, 2020
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemiaSophie Ottema, Roger Mulet-Lazaro, H Berna Beverloo, et al.
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Blood|October 8, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemiaDorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, et al.
Cancer Discovery|May 13, 2021
Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in LeukemiaLeonie Smeenk, Sophie Ottema, Roger Mulet-Lazaro, et al.
Cell Reports|July 31, 2024
STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemiaAlexander Fischer, Benjamín Hernández-Rodríguez, Roger Mulet-Lazaro, et al.
Haematologica|December 7, 2022
Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiencyAvigail Rein, Ifat Geron, Eitan Kugler, et al.
Nature Communications|July 7, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemiaRoger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, et al.
Hemasphere|August 21, 2025
Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALLRoger Mulet-Lazaro, Anikó Sijs-Szabó, Remco M Hoogenboezem, et al.
Blood|June 16, 2022
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemiaAtsushi Tanaka, Taizo A Nakano, Masaki Nomura, et al.
Blood Advances|March 26, 2025
Hematological phenotypes in GATA2 deficiency syndrome arise from aging, maladaptation to proliferation, and somatic eventsJuncal Fernandez-Orth, Cansu Koyunlar, Julia Miriam Weiss, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Blood|March 29, 2020
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemiaSophie Ottema, Roger Mulet-Lazaro, H Berna Beverloo, et al.
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Blood|October 8, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemiaDorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, et al.
Cancer Discovery|May 13, 2021
Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in LeukemiaLeonie Smeenk, Sophie Ottema, Roger Mulet-Lazaro, et al.
Cell Reports|July 31, 2024
STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemiaAlexander Fischer, Benjamín Hernández-Rodríguez, Roger Mulet-Lazaro, et al.
Haematologica|December 7, 2022
Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiencyAvigail Rein, Ifat Geron, Eitan Kugler, et al.
Nature Communications|July 7, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemiaRoger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, et al.
Hemasphere|August 21, 2025
Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALLRoger Mulet-Lazaro, Anikó Sijs-Szabó, Remco M Hoogenboezem, et al.
Blood|June 16, 2022
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemiaAtsushi Tanaka, Taizo A Nakano, Masaki Nomura, et al.
Blood Advances|March 26, 2025
Hematological phenotypes in GATA2 deficiency syndrome arise from aging, maladaptation to proliferation, and somatic eventsJuncal Fernandez-Orth, Cansu Koyunlar, Julia Miriam Weiss, et al.
Pageof 3